There are no gastroenterology clinics in public hospitals, yet we are expected to be pioneers in introducing new therapies that are not scientifically proven, at least in relation to the treatment of conditions such as Ulcerative Colitis and Crohn’s Disease. The decision of the Pharmaceutical Services, as a consequence of the strict austerity measures imposed on the healthcare sector, to introduce biosimilar medicines has raised serious concerns among patients, who are calling on the Ministry of Health to approach healthcare issues with greater sensitivity. Health cannot be measured in monetary terms, stresses the Cyprus Crohn’s and Colitis Association (CYCCA). The above excerpt is taken from an interview given by the President of CYCCA to the newspaper Haravgi. To read the full interview, please follow the link below: Click here  ...